AU2850989A - Recombinant human interleukin-1 alpha polypeptides - Google Patents

Recombinant human interleukin-1 alpha polypeptides

Info

Publication number
AU2850989A
AU2850989A AU28509/89A AU2850989A AU2850989A AU 2850989 A AU2850989 A AU 2850989A AU 28509/89 A AU28509/89 A AU 28509/89A AU 2850989 A AU2850989 A AU 2850989A AU 2850989 A AU2850989 A AU 2850989A
Authority
AU
Australia
Prior art keywords
recombinant human
human interleukin
alpha polypeptides
polypeptides
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU28509/89A
Other versions
AU616461B2 (en
Inventor
Peter T. Lomedico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU2850989A publication Critical patent/AU2850989A/en
Application granted granted Critical
Publication of AU616461B2 publication Critical patent/AU616461B2/en
Assigned to F. HOFFMANN-LA ROCHE AG reassignment F. HOFFMANN-LA ROCHE AG Alteration of Name(s) in Register under S187 Assignors: F. HOFFMANN-LA ROCHE AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28509/89A 1988-01-15 1989-01-13 Recombinant human interleukin-1 alpha polypeptides Ceased AU616461B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14445788A 1988-01-15 1988-01-15
US144457 1988-01-15

Publications (2)

Publication Number Publication Date
AU2850989A true AU2850989A (en) 1989-07-20
AU616461B2 AU616461B2 (en) 1991-10-31

Family

ID=22508674

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28509/89A Ceased AU616461B2 (en) 1988-01-15 1989-01-13 Recombinant human interleukin-1 alpha polypeptides

Country Status (19)

Country Link
EP (1) EP0324447B1 (en)
JP (1) JP2567079B2 (en)
AR (1) AR245958A1 (en)
AT (1) ATE142696T1 (en)
AU (1) AU616461B2 (en)
DE (1) DE58909723D1 (en)
DK (1) DK16489A (en)
ES (1) ES2091752T3 (en)
FI (1) FI890175A (en)
GR (1) GR3021887T3 (en)
HU (1) HU208996B (en)
IE (1) IE890087L (en)
IL (1) IL88934A (en)
MC (1) MC2002A1 (en)
NO (1) NO890174L (en)
NZ (1) NZ227594A (en)
PT (1) PT89438B (en)
YU (1) YU6889A (en)
ZA (1) ZA89202B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587605T2 (en) * 1984-12-25 1994-03-17 Dainippon Pharmaceutical Co Interleukin-1 and its derivative.
DE3818660A1 (en) * 1987-06-05 1988-12-15 Colgate Palmolive Co FREE-FLOWING, POWDERY DISHWASHING DETERGENT AND METHOD FOR PRODUCING THE SAME
US5120534A (en) * 1988-07-29 1992-06-09 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and medicament for treating thrombocytopenia
US6191269B1 (en) * 1997-05-30 2001-02-20 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US7176179B1 (en) 1997-05-30 2007-02-13 The Regents Of The University Of California Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
US20030154504A1 (en) 1998-06-24 2003-08-14 Farese Robert V. Methods and compositions for modulating carbohydrate metabolism
DE10252634A1 (en) * 2002-11-11 2004-05-27 Umwelttechnik Georg Fritzmeier Gmbh & Co. Purification of sewage or other substances laden with harmful organic matter and detergent or clarifying agent also useful laundry and cleaning surfaces involve introduction of photosensitizer releasing singlet oxygen when stimulated
EP2464330B1 (en) * 2009-09-29 2016-03-23 United Technologies UT AG Oral care compositions containing human recombinant interleukin-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587605T2 (en) * 1984-12-25 1994-03-17 Dainippon Pharmaceutical Co Interleukin-1 and its derivative.
DE3683186D1 (en) * 1985-04-25 1992-02-13 Hoffmann La Roche RECOMBINANT HUMANINTERLEUKIN-1.
DE3515217A1 (en) * 1985-04-26 1986-10-30 Siemens AG, 1000 Berlin und 8000 München DEVICE FOR MEASURING LOW MAGNETIC FIELDS
US5017692A (en) * 1986-09-04 1991-05-21 Schering Corporation Truncated human interleukin-a alpha

Also Published As

Publication number Publication date
HUT50505A (en) 1990-02-28
FI890175A0 (en) 1989-01-13
ATE142696T1 (en) 1996-09-15
MC2002A1 (en) 1990-01-26
HU208996B (en) 1994-09-28
DE58909723D1 (en) 1996-10-17
FI890175A (en) 1989-07-16
NZ227594A (en) 1991-09-25
IL88934A0 (en) 1989-08-15
AU616461B2 (en) 1991-10-31
JP2567079B2 (en) 1996-12-25
PT89438B (en) 1993-09-30
DK16489D0 (en) 1989-01-13
DK16489A (en) 1989-07-16
PT89438A (en) 1990-02-08
YU6889A (en) 1990-08-31
EP0324447A2 (en) 1989-07-19
JPH025892A (en) 1990-01-10
NO890174D0 (en) 1989-01-13
IE890087L (en) 1989-07-15
EP0324447A3 (en) 1990-01-31
ES2091752T3 (en) 1996-11-16
GR3021887T3 (en) 1997-03-31
EP0324447B1 (en) 1996-09-11
AR245958A1 (en) 1994-03-30
NO890174L (en) 1989-07-17
ZA89202B (en) 1989-09-27
IL88934A (en) 1994-05-30

Similar Documents

Publication Publication Date Title
AU585180B2 (en) Nor-statine and nor-cyclostatine polypeptides
AU4005289A (en) Recombinant saccharomyces
AU3601689A (en) Recombinant coccidiosis vaccines
AU3362889A (en) Peptide derivatives
AU579089B2 (en) Human interleukin-2-like polypeptides
AU3414689A (en) Therapeutic peptides
AU4348089A (en) Knee-tilt chair control
AU6428890A (en) Therapeutic peptides and proteins
AU633294B2 (en) Motilin-like polypeptide and use thereof
AU3977589A (en) Novel peptides
AU3108389A (en) Polypeptides
AU4514093A (en) Recombinant antibody against human interleukin-1
AU2850989A (en) Recombinant human interleukin-1 alpha polypeptides
AU6161390A (en) Recombinant human thyroid peroxidase
AU4122689A (en) Human rhinovirus peptides
AU635036B2 (en) Recombinant avipoxvirus
AU5559786A (en) Recombinant human rennin
AU4588189A (en) Imidazole-containing peptide and preparation thereof
AU3804689A (en) Modified proteins
AU4022589A (en) Vaccinal Polypeptides
AU3549489A (en) Human gm-csf variants
EP0351826A3 (en) Anticoagulant polypeptide
AU3231189A (en) Recombinant endonexin ii
AU3705689A (en) Sialic acid-bonded octapeptide and preparation thereof
GB2222165B (en) Recombinant capripoxvirus